PLAB Form 144: 10,000 vested shares planned sale on NASDAQ

Rhea-AI Filing Summary

Photronics (PLAB) insider filing reports a proposed sale of 10,000 common shares that were acquired through restricted stock vesting on 01/03/2025. The shares carry an aggregate market value of $253,307.50 and the approximate sale date is 10/06/2025 on NASDAQ. The filing states the shares were issued as compensation and fully paid on 01/03/2025. The filing also discloses a prior sale by Frank K. Lee of 8,750 shares on 08/29/2025 for gross proceeds of $203,031.56. The signer certifies no undisclosed material adverse information is known.

Positive

• Shares were acquired via restricted stock vesting, indicating compensation rather than open‑market purchase
• Full disclosure of prior recent sale (8,750 shares on 08/29/2025), improving transparency
• Aggregate market value provided ($253,307.50), allowing investors to gauge transaction scale

Negative

• No filer name or CIK shown in the provided excerpt, which limits traceability to the specific insider
• Filing lacks explicit trading‑plan disclosure (no 10b5‑1 plan date noted), leaving intent/timing unclear

Insights

Corporate Insider Trading Analyst

TL;DR: A company insider plans a routine sale of vested compensation totaling 10,000 shares.

The filing shows the securities were acquired by restricted stock vesting and are being sold as personal compensation on an approximate date of 10/06/2025. The transaction size equals $253,307.50 at the reported market value, which is a modest percentage of the issuer's outstanding shares of 59,004,625.

This appears operationally routine: vesting-triggered selling, with a recent related sale of 8,750 shares on 08/29/2025. Watch filings near the sale date for actual trade execution details and any trading-plan disclosures that could clarify timing and intent within weeks.

Compliance / Corporate Counsel

TL;DR: Disclosure follows Rule 144 mechanics; the signer affirms no undisclosed material information.

The notice identifies the securities as fully paid compensation shares and includes the required seller representation that no undisclosed material adverse information is known. The presence of a prior sale in the past three months is disclosed, satisfying look‑back aggregation requirements in practice.

From a compliance standpoint, confirm whether a written trading plan (Rule 10b5‑1) exists and check subsequent Form 4 or Form 5 filings to confirm actual sale date and amounts within 10/06/2025 timeframe.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	253307.50	59004625	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2025	Restricted Stock Vesting	Issuer			10000	01/03/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frank K. Lee 15 Secor Road15 Brookfield CT 06804	Common	08/29/2025	8750	203031.56

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Photronics (PLAB) report?

It reports a proposed sale of 10,000 common shares acquired by restricted stock vesting on 01/03/2025 with an aggregate market value of $253,307.50 and an approximate sale date of 10/06/2025 on NASDAQ.

Who previously sold the issuer's shares in the past three months?

The filing discloses a prior sale by Frank K. Lee of 8,750 shares on 08/29/2025 for gross proceeds of $203,031.56.

How were the 10,000 shares acquired by the seller?

The shares were acquired through restricted stock vesting and paid as compensation on 01/03/2025.

Where will the proposed sale occur and when?

The approximate sale date is 10/06/2025 and the filing lists NASDAQ as the securities exchange.

Does the filing state whether the seller knows any undisclosed material information?

Yes, the signer represents by signature that they do not know any material adverse information regarding current or prospective operations that has not been publicly disclosed.